Efficacy and Safety of CLIFE1 Gel in Benign Anorectal Surgery
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Double-blinded multicenter randomized clinical trial to evaluate the efficacy and safety of
CLIFE2 (lidocaine, referred as treatment A) respect CLIFE1 (lidocaine plus diclofenac,
referred as treatment B) in benign anorectal surgery.